Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma.

Autor: Jiaxin Han1, Wentao Kuai1,2,3, Liu Yang1, Xuemei Tao1, Yuekui Wang1, Minghui Zeng1, Yuqin Li1, Yuqiang Mi1,2,3, Ningning Zhang4 mail4ningning@163.com, Wei Lu4 mail4luwei@tmu.edu.cn, Liang Xu1,2,3 xuyangliang2004@sina.com
Zdroj: Cancer Biology & Medicine. Sep2024, Vol. 21 Issue 9, p813-825. 13p.
Databáze: Academic Search Ultimate